MAAT PHARMA SACA (MAAT.PA) Stock Earnings & Estimates
Europe - Euronext Paris - EPA:MAAT - FR0012634822 - Common Stock
5.12 EUR
-0.38 (-6.91%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.43M 47.12% | 2.228M 55.80% | 3.216M 44.34% | 13.609M 323.17% | 13.377M -1.70% | 20.91M 56.31% | 96.025M 359.23% | 204.36M 112.82% | 350.93M 71.72% | 474.25M 35.14% | 604.4M 27.44% | |
| EBITDA YoY % growth | -13.128M -53.27% | -19.13M -45.72% | -26.31M -37.53% | -25.245M 4.05% | -29.045M -15.05% | -36.686M -26.31% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.557M -52.45% | -20M -47.53% | -28M -40.00% | -25.514M 8.88% | -29.311M -14.88% | -27.201M 7.20% | 198.099K 100.73% | 68.245M 34,350.01% | 134.61M 97.25% | 215.43M 60.04% | 303.78M 41.01% | |
| Operating Margin | -948.04% | -897.67% | -870.65% | -187.48% | -219.11% | -130.09% | 0.21% | 33.39% | 38.36% | 45.43% | 50.26% | |
| EPS YoY % growth | N/A 20.24% | N/A -37.87% | N/A -12.99% | -3.18 -52.83% | -3.41 -7.42% | -3.39 0.65% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.427M 41.02% | % | ||
| Q4 2024 Q2Q % growth | 1.495M 75.88% | % | ||
| Q2 2024 Q2Q % growth | 1.721M 24.89% | % | ||
| Q4 2023 Q2Q % growth | 850K -9.19% | % | ||
| Q2 2023 Q2Q % growth | 1.378M 178.95% | % | ||
| Q4 2022 Q2Q % growth | 936K 59.45% | % | ||
| Q2 2022 Q2Q % growth | 494K 28.31% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -64.33% |
| Revenue | N/A | N/A | 0% | 50.33% |